Literature DB >> 9021357

Diversity of the blocking effects of antisperm antibodies on fertilization in human and mouse.

H Shibahara1, M Shigeta, M Inoue, A Hasegawa, K Koyama, N J Alexander, S Isojima.   

Abstract

The blocking effects of complement-dependent sperm immobilizing antibodies in the sera of infertile women and monoclonal antisperm antibodies against humans and mice on fertilization were investigated. The hemizona assay (HZA) and sperm penetration assay (SPA) were used to study the inhibitory effects of sera from 22 infertile patients positive for sperm immobilizing antibodies. Use of these tests allowed us to differentiate whether the antibody blocked sperm-zona pellucida tight binding and/or sperm penetration into the ooplasm. The zona pellucida penetration assay (ZPA) was also used to study the effects of four monoclonal antibodies (mAbs) on human sperm penetration into the zona pellucida. Seven mAbs against murine spermatozoa were tested for their inhibitory effects on in-vitro fertilization (IVF) and HZA in mice. Of 22 patient sera with sperm immobilizing antibodies, 21 (95.5%) inhibited HZA attachment and penetration, whereas this did not occur in any of 13 patient sera without these antibodies. However, 19 of 22 (86.4%) patient sera with sperm immobilizing antibodies and eight of 13 (61.5%) patient sera without these antibodies inhibited the SPA. Two (2C6, 1G12) of four mAbs against human spermatozoa showed strong inhibitory effects in all the assays (HZA, ZPA and SPA). One mAb (3B10) did not inhibit HZA but blocked ZPA and SPA. Another mAb (H6-3C4) seemed to have no inhibitory effects on fertilization. Two (Vx 5 and Vx 8) of seven mAbs against murine spermatozoa inhibited IVF in mice but did not block mouse HZA. These findings suggest that antisperm antibodies block fertilization at specific stages. Some of them may inhibit sperm capacitation and thus prevent all processes of fertilization that follow. Some other antibodies may not affect capacitation and sperm binding to zona pellucida but inhibit the acrosome reaction, followed by the blocking of sperm penetration through zona pellucida and ooplasm.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9021357     DOI: 10.1093/oxfordjournals.humrep.a019176

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Effects of in vivo exposure to eggs with sperm-immobilizing antibodies in follicular fluid on subsequent fertilization and embryo development in vitro.

Authors:  Hiroaki Shibahara; Yuki Hirano; Yasuko Shiraishi; Kazuhiko Shimada; Kumiko Kikuchi; Tatsuya Suzuki; Satoru Takamizawa; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2006-05-19

Review 2.  Diagnosis and treatment of immunologically infertile males with antisperm antibodies.

Authors:  Hiroaki Shibahara; Yasuko Shiraishi; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2005-05-03

3.  Infertile women without sensitization to an appropriate amount of sperm do not produce sperm-immobilizing antibodies in their sera.

Authors:  Hiroaki Shibahara; Kumiko Kikuchi; Yasuko Shiraishi; Mitsuaki Suzuki; Minoru Shigeta; Koji Koyama
Journal:  Reprod Med Biol       Date:  2003-09-26

4.  Toward standardization of the cut-off value for the direct immunobead test using the postcoital test in immunologically infertile males.

Authors:  Junko Koriyama; Hiroaki Shibahara; Tomoe Ikeda; Yuki Hirano; Tatsuya Suzuki; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2012-08-09

Review 5.  Antisperm antibodies and conception.

Authors:  L W Chamley; G N Clarke
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

Review 6.  Sex difference in anti-sperm antibodies.

Authors:  Hiroaki Shibahara; Yuekun Chen; Haruka Honda; Yu Wakimoto; Atsushi Fukui; Akiko Hasegawa
Journal:  Reprod Med Biol       Date:  2022-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.